X

Month: January 2026

Earnings Summary: DR Horton reports lower revenue and profit for Q1 FY26

Homebuilder D.R. Horton, Inc. (NYSE: DHI) on Tuesday reported a year-over-year decline in revenues and earnings for the first quarter of…

Plus Therapeutics CEO On Radiopharmaceuticals

Marc Belsky, CEO of Plus Therapeutics, discusses advances in radiopharmaceutical treatments for cancer. On Technology Q: Can you explain Plus…

Inspire Veterinary Partners CEO On Consolidation

Kimball Carr, CEO of Inspire Veterinary Partners, discusses the veterinary practice consolidation opportunity and the company's growth strategy. On Industry…

Earnings Preview: Will Boeing’s (BA) Q4 FY25 results benefit from recovery efforts?

The Boeing Company (NYSE: BA) has entered a critical phase in its turnaround efforts, following an extended period of financial…

Forestar Group Reports Q1 Fiscal 2026 Results; Revenue Up 9% as Lot Development Activity Continues

Forestar Group Inc. (NYSE: FOR), a residential lot development company and majority-owned subsidiary of D.R. Horton, Inc., reported First Quarter…

Fifth Third Bancorp Shares Tick Up After Quarterly Profit Increase

Fifth Third Bancorp (NASDAQ: FITB) shares traded at $50.21 at market close on Tuesday, up modestly on the day with…

Mercantile Bank Corporation Reports Strong Q4 and Full-Year 2025 Results; Net Income Up 12% YoY

Mercantile Bank Corporation (NASDAQ: MBWM), the largest Michigan-founded, headquartered, and serving bank, reported Fourth Quarter and Full-Year 2025 Results on…

Infographic: How US Bancorp (USB) performed in Q4 2025

US Bancorp (NYSE: USB) reported its earnings results for the fourth quarter of 2025. Total net revenue increased 5.1% year-over-year…

Rezolve Ai CEO On Commerce Transformation

Daniel Wagner, CEO of Rezolve Ai, discusses how artificial intelligence is transforming commerce experiences. On AI Applications Q: How is…

OS Therapies CEO On Osteosarcoma Treatment

Paul Romness, CEO of OS Therapies, discusses the company's commitment to developing treatments for osteosarcoma. On Unmet Need Q: Why…